Peer-reviewedCC BYJournal of medical cases
Beyond Steroids: Mycophenolate Mofetil Dosing in Immune Checkpoint Inhibitor-Mediated Hepatitis
- 1Rutgers Health/Community Medical Center, Toms River, NJ, USA
Related
- Immune Checkpoint Inhibitor-Related Hepatitis Versus Classical Autoimmune Hepatitis: A Retrospective Multidomain Phenotype Comparison
- 993 Optimizing management of immune checkpoint inhibitor-mediated toxicity in cancer patients
- First-line fecal microbiota transplantation for the management of immune checkpoint inhibitor-mediated diarrhea and colitis
- Immune checkpoint inhibitor-associated interstitial nephritis: let’s move forward addressing the unknowns
- Fatal Coronary and Mesenteric Vasculopathy With Immune Checkpoint Inhibitor Therapy
BibTeX
@article{shambhavi2026beyond,
title = {{Beyond Steroids: Mycophenolate Mofetil Dosing in Immune Checkpoint Inhibitor-Mediated Hepatitis}},
author = {Shreya Shambhavi and Aksa Alina Joy and Emilia Wilk and Chirag Shah},
journal = {Journal of medical cases},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13661094},
note = {CC BY},
}
RIS
TY - JOUR
TI - Beyond Steroids: Mycophenolate Mofetil Dosing in Immune Checkpoint Inhibitor-Mediated Hepatitis
AU - Shreya Shambhavi
AU - Aksa Alina Joy
AU - Emilia Wilk
AU - Chirag Shah
PY - 2026
DA - 2026/10/02
JO - Journal of medical cases
UR - https://europepmc.org/article/PMC/PMC13661094
SN - 1923-4155
ER -